Capital Advisory

Truly Health Minded

We support healthcare entrepreneurs in all of their capital challenges: M&A and Fundraising Advice

expertise

THM Capital Advisory advises Healthcare entrepreneurs for their capital needs at every stage of companies’ lifecycles

We cover all Health segments

Medtech

Intervenant lors d’un congrès médical représentant les services à la santé.

health services

biotech

Médecin utilisant une tablette pour illustrer les solutions de santé digitale.

digital health

Professionnels de santé analysant des images médicales représentant médecines libérales.

liberal medicine

We support your projects in the fields of software publishing, data processing, telemedicine, SaMD (Software as Medical Device), connected devices and DTx.

We support your projects in the fields of clinical research (CRO), CDMOs, medical education (media and conferences) and distribution.

We support your projects implantable devices, non-implantable devices, surgical instrumentation, and diagnostic solutions.

We support your projects linked to the consolidation of medical specialties such as radiology, ophthalmology, dental offices or even analysis laboratories.

We support your projects of biotherapies, TechBio platforms, immunotherapies, cell and gene therapies, and vaccines.

About

One team. Double expertise.

We choose our customers carefully and pay particular attention to the quality of our relationship.

Independent and committed, we defend their interests with rigor and loyalty. By their side until the end, we work tirelessly, combining strategic thinking and tactical agility to negotiate the best terms.

Our team brings together seasoned financial profiles and senior advisors, health experts.
‍
‍This double expertise, financial and medical, allows us to well understand the challenges of our customers and to support them in a relevant way.

Learn more about us See the team

testimonies

They trust us

“THM Capital Advisory fully understood the technological value of Caerus Medical and the value of backing up to accelerate its development. Their support made it possible to achieve a great deal with Gleamer, a leader in imaging diagnostics. Thanks to its expertise, THM is an ideal partner to align the interests of stakeholders during this key phase.”

David Vittecoq

CEO @ Caerus Medical

“One of the great assets of THM Capital Advisory is their ability to connect entrepreneurs with the right investors, i.e. those who understand the project and support our mission. Thanks to their network of private investors and their very targeted approach, we were able to structure a very substantial fundraiser for Womed. I highly recommend them to Medtech entrepreneurs.”

Gonzague Issenmann

Executive Chaiman & CEO @ Womed

“Since our first round in 2022, THM Capital Advisory has been a real long-term partner. Their listening and understanding of our project made it possible to build a relationship of trust and to conclude the next two phases. A human and committed team that transforms ambitions into concrete deals.”

Silvina Ramella

Chairwoman @ Advanced Life Solutions

“The sale of Thélème was an important step for the company and for me. THM Capital Advisory was able to structure an efficient process and support us until a merger with EDL, one of the 2 market leaders, in excellent conditions.”

Grégoire Sharpin

Executive Chairman @ Thélème

“We gave a sale mandate to THM Capital Advisory after an unsatisfactory initial offer. Their ability to structure a competitive process made it possible to multiply the final price by 3.5 times. Support that is both reassuring and very effective, particularly suited to doctors who are unfamiliar with these operations.”

Bernard Mamou-Mani

Radiologue @ Groupe d’Imagerie Chauny

“In a particularly constrained biotech financing environment, the THM Capital Advisory team was able to structure and conclude our B1 Series with remarkable efficiency, in record time. Their commitment and deep understanding of our project played a key role in the success of the operation. We are particularly grateful to them.”

Florent Gros

CEO @ Priothera

“In a complicated context for fundraising, the THM Capital Advisory team remained fully committed to our side. Their determination and their ability to maintain the momentum of the process were key to success. Beyond their technical expertise, it is their true spirit of partnership that has made all the difference.”

Nicolas Maciocia

CEO @ WeKare

transactions